Desvenlafaxine Reference Standard: Applications in Pharmaceutical Analysis
In modern pharmaceutical quality control, reliable reference standards are essential for accurate identification, assay determination, impurity profiling, and analytical method validation. Desvenlafaxine is an important active pharmaceutical ingredient (API) belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class and is widely investigated in pharmaceutical development and quality-control laboratories.
A properly characterized Desvenlafaxine Reference Standard provides analysts with a dependable comparison material for chromatographic and spectroscopic procedures. It can support routine quality testing, stability studies, forced-degradation investigations, impurity characterization, and regulatory documentation.
Chemicea Pharmaceuticals provides Desvenlafaxine and a range of related compounds and impurity standards designed to support pharmaceutical research, analytical development, and quality-control requirements.
Understanding Desvenlafaxine
Desvenlafaxine is also known as O-Desmethyl Venlafaxine and is the major active metabolite of venlafaxine. Chemically, the compound is identified as 4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol. Chemicea lists Desvenlafaxine under CAT. No. CP-D16005, with CAS No. 93413-62-8, molecular formula C16H25NO2, and molecular weight approximately 263.4 g/mol.
The compound is also available in different salt forms, including desvenlafaxine succinate and desvenlafaxine succinate monohydrate. These forms can have different analytical and physicochemical characteristics and therefore require appropriate reference materials during pharmaceutical testing.
The USP monograph identifies Desvenlafaxine as C16H25NO2 with CAS No. 93413-62-8 and specifies an assay range of 98.0% to 102.0% on the dried basis. The monograph also identifies Desvenlafaxine Reference Standard and related reference materials for pharmaceutical testing.
Why Desvenlafaxine Reference Standards Matter
Pharmaceutical laboratories cannot rely exclusively on the API sample being tested when making analytical decisions. A reference standard provides a known comparator against which an unknown sample can be evaluated.
For Desvenlafaxine, a reference standard may be used to:
Confirm the identity of the API.
Support assay and purity determination.
Establish chromatographic retention characteristics.
Assist in related-substance analysis.
Support analytical method development.
Validate quantitative HPLC or LC-MS methods.
Evaluate samples during stability studies.
Investigate degradation pathways.
Support forced-degradation experiments.
Assist pharmaceutical manufacturers with regulatory documentation.
The value of a reference standard becomes especially important when the laboratory needs to distinguish the API from structurally related compounds, process-related impurities, degradation products, or metabolites.
Role in HPLC and Chromatographic Analysis
High-performance liquid chromatography (HPLC) is one of the most important analytical techniques used for pharmaceutical quality control. Desvenlafaxine reference material can be used to establish retention characteristics and confirm the identity of the principal chromatographic peak.
USP information for desvenlafaxine extended-release tablets describes liquid chromatographic procedures for dissolution and organic-impurity testing. Depending on the procedure, different stationary phases and chromatographic conditions can be used, demonstrating the importance of selecting suitable analytical conditions for the intended purpose.
During method development, analysts may inject a Desvenlafaxine Reference Standard separately and compare its retention time and detector response with those obtained from a formulation or API sample. This can help establish peak identity before proceeding with quantitative analysis.
For impurity methods, the API reference standard can also be combined with individual impurity standards to assess chromatographic separation and system suitability.
Application in Analytical Method Validation
Analytical method validation is a fundamental part of pharmaceutical development. A method intended for quantitative or qualitative analysis should demonstrate appropriate characteristics such as specificity, accuracy, precision, linearity, range, and robustness according to its intended application.
A Desvenlafaxine Reference Standard can be incorporated into several stages of method validation.
Specificity
Specificity is particularly important when the API is analyzed in the presence of structurally related compounds. The reference standard establishes the chromatographic response of Desvenlafaxine, while impurity standards can be used to determine whether potentially interfering compounds are adequately separated.
Accuracy
Known quantities of the reference material can be used during recovery experiments to evaluate the accuracy of an analytical procedure.
Precision
Reference-standard solutions may be analyzed repeatedly to evaluate repeatability and intermediate precision under defined laboratory conditions.
Linearity
Multiple concentration levels prepared from a characterized reference standard can contribute to establishing the relationship between concentration and analytical response.
Robustness
Reference-standard solutions can also be useful when evaluating the effect of deliberate changes in chromatographic parameters, such as mobile-phase composition, flow rate, column temperature, or detection conditions.
Impurity Profiling of Desvenlafaxine
One of the most important applications of reference standards is impurity profiling. Pharmaceutical impurities can originate from starting materials, intermediates, manufacturing processes, degradation reactions, storage conditions, or interactions with formulation components.
For Desvenlafaxine, Chemicea's product portfolio includes several related substances and impurity standards. These include Desvenlafaxine Benzyl Ether, Desvenlafaxine N,N-Didesmethyl Impurity, Desvenlafaxine Phenol Impurity, Desvenlafaxine R-Isomer, Desvenlafaxine S-Isomer, and Desvenlafaxine Spiro Impurity.
Having individual reference materials for these compounds can make impurity identification and quantification more reliable.
For example, a laboratory detecting an unknown secondary peak during an HPLC analysis may compare its retention behavior with an authentic impurity standard. If appropriate chromatographic and spectroscopic evidence supports the assignment, the reference material can contribute to the identification and characterization process.
Desvenlafaxine and Related Nitrosamine Standards
Nitrosamine impurities have become an important consideration in pharmaceutical quality assessment. Their potential formation depends on chemical structures, manufacturing conditions, raw materials, and process chemistry.
Chemicea's Desvenlafaxine portfolio includes several nitrosamine-related materials, including N-Nitroso Desvenlafaxine Impurity 5, N-Nitroso Desvenlafaxine Impurity 4, N-Nitroso Desmethyl Desvenlafaxine, and N-Nitroso Desvenlafaxine Impurity 1.
Such compounds can be relevant to specialized analytical investigations where laboratories need highly specific standards for trace-level detection and characterization.
For laboratories developing LC-MS/MS methods, having authentic target compounds can be particularly valuable because chromatographic retention alone may not be sufficient for confident identification at low concentrations.
LC-MS and Advanced Analytical Applications
Mass spectrometry provides an additional level of selectivity compared with conventional UV detection. Desvenlafaxine has been investigated using LC-ESI-MS/MS methods for quantitative analysis, including applications involving biological samples. One published method used desvenlafaxine-d6 as an internal standard and demonstrated high sensitivity and precision across its validated concentration range.
Reference standards are important in LC-MS workflows because analysts need authentic compounds to establish mass spectral characteristics, retention behavior, and quantitative response.
Depending on the analytical objective, Desvenlafaxine standards may therefore support:
LC-MS method development.
LC-MS/MS quantification.
Structural confirmation.
Metabolite investigations.
Pharmacokinetic studies.
Trace-level impurity analysis.
Bioanalytical method development.
Stable-isotope-labeled standards may also be useful in quantitative bioanalysis when an isotopically labeled analogue is required as an internal standard.
Stability and Forced-Degradation Studies
Stability studies evaluate how an API or finished dosage form behaves under defined environmental conditions. Temperature, humidity, light, oxidation, hydrolysis, and other stress conditions can contribute to chemical changes.
Forced-degradation studies intentionally expose the drug substance or product to stress conditions to generate degradation products. The objective is not simply to produce degradation, but to demonstrate that the analytical method can distinguish the intact API from its degradation products.
A Desvenlafaxine Reference Standard provides the baseline analytical profile against which stressed samples can be compared.
Researchers can compare:
Unstressed Desvenlafaxine → Stressed Desvenlafaxine → New degradation peaks
This approach helps establish whether the analytical method is stability-indicating and whether additional reference standards are required for identification of significant degradation products.
Desvenlafaxine Salt Forms and Analytical Considerations
Desvenlafaxine can exist in different chemical forms. USP separately describes Desvenlafaxine Succinate, including its monohydrate and anhydrous forms. The monohydrate has a molecular formula incorporating one molecule of water and a molecular weight of 399.48 g/mol, while the anhydrous salt has a molecular weight of 381.47 g/mol.
This distinction is important for pharmaceutical laboratories because analytical calculations, reference materials, and specifications may depend on the form being evaluated.
Chemicea lists both Desvenlafaxine Succinate and Desvenlafaxine Succinate Monohydrate in its related-product portfolio.
Using the appropriate reference material helps minimize errors arising from differences in salt form, hydration state, molecular weight, or analytical basis.
Supporting Regulatory and Quality-Control Activities
Reference standards are also valuable during regulatory submissions and ongoing quality-control activities. Pharmaceutical companies may require well-characterized standards while preparing documentation associated with:
API specifications.
Finished-product specifications.
Analytical procedures.
Method validation reports.
Stability studies.
Impurity qualification.
Regulatory submissions.
Batch-release testing.
Investigations of atypical chromatographic results.
USP's current information for desvenlafaxine extended-release tablets identifies USP Desvenlafaxine RS, Desvenlafaxine Related Compound A RS, Desvenlafaxine Related Compound B RS, Desvenlafaxine Succinate RS, and Venlafaxine Hydrochloride RS among reference standards used for the compendial framework.
This illustrates how reference materials can form an important component of a broader analytical control strategy.
Chemicea's Desvenlafaxine Reference Standard Portfolio
Chemicea Pharmaceuticals supports pharmaceutical analytical requirements through a portfolio covering APIs, process impurities, degradation products, metabolites, nitrosamine-related compounds, and other specialized reference materials.
For Desvenlafaxine, Chemicea lists the API reference standard along with multiple related substances. The company's product page also identifies applications such as method validation, ANDA filing, forced-degradation studies, identification standards, and DMF-related analytical requirements.
Several Desvenlafaxine-related compounds are available from stock, while others are offered through custom synthesis. This model can be useful for laboratories that require a less common impurity that may not be readily available through conventional commercial catalogs.
Chemicea also provides analytical documentation such as certificates of analysis and material safety data information for its products, supporting laboratory evaluation and procurement workflows.
Custom Synthesis for Specialized Desvenlafaxine Impurities
Not every pharmaceutical project involves commonly available impurities. During process development, degradation studies, or regulatory investigations, laboratories may encounter compounds that require specialized synthesis.
Chemicea's capabilities in custom synthesis can help address these requirements. Its Desvenlafaxine portfolio demonstrates this approach through products such as Desvenlafaxine Benzyl Ether, Desvenlafaxine R-Isomer, Desvenlafaxine S-Isomer, Desvenlafaxine Spiro Impurity, and several nitrosamine-related compounds listed as custom-synthesis materials.
Custom synthesis can therefore be valuable when a laboratory requires a specific structural analogue for peak identification, analytical method development, impurity qualification, or research purposes.
Conclusion
The Desvenlafaxine Reference Standard is an important analytical resource for pharmaceutical laboratories involved in API characterization, quality control, impurity profiling, method validation, stability testing, and advanced chromatographic analysis.
Because Desvenlafaxine can be evaluated alongside structurally related impurities, degradation products, stereoisomers, salt forms, and nitrosamine-related compounds, access to appropriate reference materials can significantly strengthen an analytical control strategy.
Chemicea Pharmaceuticals supports these requirements through its Desvenlafaxine reference standard and related impurity portfolio, including both readily available materials and compounds offered through custom synthesis. By combining pharmaceutical reference standards with specialized synthesis capabilities, Chemicea can support analytical development, quality-control laboratories, pharmaceutical manufacturers, CROs, and research organizations working on Desvenlafaxine-related projects.
For laboratories requiring reliable materials for method validation, impurity profiling, forced-degradation studies, regulatory analytical work, LC-MS/MS development, or pharmaceutical quality control, a suitably characterized Desvenlafaxine Reference Standard provides an essential foundation for generating consistent and scientifically defensible analytical results.
Comments